Calidi Biotherapeutics, Inc.

CLDICIK 0001855485 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 27, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0137Δ-0.000584% similar+718/-880 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 29, 20261.01 · Entry into a Material Definitive Agreeme3.02 · Unregistered Sales9.01 · Financial Statements and Exhibits May 14, 2026no items parsed May 8, 2026no items parsed Apr 2, 2026no items parsed Mar 27, 2026no items parsed

YoY shift: Neutral

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.05pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Calidi Biotherapeutics, Inc.

Name	Roles	Filings
Fernandez Santidrian Antonio	Officer	1
First Light Acquisition Group, LLC	10% Owner	1
Gerber Sander	10% Owner	1
Hudson Bay Capital Management LP	10% Owner	1
Lee Heehyoung	Director	1

Showing 11-15 of 18

Per pagePrevPage 3 of 4Next

All filings

44 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Dec 16, 2025	Camaisa Allan Director	SSale	850	$1.455	$1,237
Sep 5, 2025	Fernandez Santidrian Antonio Chief Scientific Officer	Holdings only	-	-	-
Sep 5, 2025	Jackson Andrew C. Chief Financial Officer	Holdings only	-	-	-
Sep 5, 2025	Poma Eric E Chief Executive Officer	Holdings only	-	-	-
Aug 25, 2025	Jackson Andrew C. Chief Financial Officer	PPurchase	2,500	$2.00	$5,000

Showing 1-5 of 44

Per pagePage 1 of 9Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value